Cancer is a genetic disease caused by 'gain of function' mutations of
oncogenes and 'loss of function' mutations of tumour suppressors and o
f genes involved in DNA repair mechanisms, The RET gene encodes a tyro
sine kinase receptor for molecules belonging to the glial cell line-de
rived neurotrophic factor (GDNF) family. RET is a paradigmatic example
of how different mutations of a single gene can lead to different neo
plastic phenotypes, Indeed, gene rearrangements, often caused by chrom
osomal inversions, activate the oncogenic potential of RET in a fracti
on of human thyroid papillary carcinomas. On the other hand, different
point mutations activate RET in familial multiple endocrine neoplasia
syndromes familial medullary thyroid carcinoma (FMTC), MEN-2A and MEN
-2B. Little information is so far available on the biochemical mechani
sms by which the potent transforming and mitogenic signals of RET are
delivered to the nucleus. However, recent data indicate coupling to th
e Shc-Ras-MAPK pathway as a necessary step in RET signal transduction.